Biotech Firm Galapagos NV Pegs Rosier $250M IPO Goal
Belgian biotech company Galapagos NV has upped its expectations for its approaching initial public offering, announcing on Tuesday that it will now offer 6 million shares in an offering it now...To view the full article, register now.
Already a subscriber? Click here to view full article